The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 10.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (6 analysts) rates it buy, with a mean price target of $15.
Saudi British Bank
1030.SR · TADAWUL · SAR · Market cap $16.6B · 1,490 employees
The Saudi Investment Bank provides commercial and retail banking services to individuals, small to medium-sized businesses, and corporate and institutional customers in the Kingdom of Saudi Arabia.
FAIL · Does not pass the screenScreen close, 2026-09-21 · not a live quote
Last reviewed 16 days ago
Screened 2026-09-21 · the tape above runs as of 23:45 UTC · 6 Oct · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 14.63 against the desk's fair-value range, base estimate 14.32, over the last year.
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Saudi British Bank holds its Accumulation at $14.63. Consolidating, no directional conviction, held for 106 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 106 days |
| Price at the screen | $14.63 |
| Valuation | 8.66 trailing · 9.32 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.30 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Bank — FAIL on business activity | Fail |
| Debt load | 1.71% | Below 33% | Interest-bearing debt is just 1.7% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 4.31% | Below 33% | Cash held in interest-bearing accounts and securities is 4.3% of assets, under the one-third limit. | Pass |
| Receivables | 0.07% | Below 49% | Money owed to the company is 0.1% of assets, under the 49% limit. | Pass |
| Revenue purity | -0.21% | Below 5% | Only -0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Saudi British Bank does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $14.32 fair value estimate, 1.00% revenue growth.
Fair value range in SAR, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. The price runs 2.2% above the base estimate.
Third-party analyst targets: 6 covering, consensus None. The average target sits −1% from the screen price.
Reading the gap · Our model and the Street both land near the screened price: fairly valued, with no strong edge either way.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 9.3x forward earnings, the price already runs ahead of the business. It trades 2% above our $14.32 fair value, so you would be buying at a premium, not a discount.
| Forward P/E | 9.3xexpensive even after accounting for its growth |
| Trailing P/E | 8.7xvery cheap relative to earnings |
| EPS, trailing | 1.69 |
| EPS, forward | 1.57 |
| Revenue growth | +1.0%slow but positive growth |
| Profit margin | 55.0%highly profitable on every dollar of sales |
| Return on equity | 11.2%a modest return on shareholder capital |
| Dividend yield | 451.00% |
| Beta | 0.30barely tracks the market's swings |
| 52-week range | 0.00 - 14.81 |
| Market cap | $16.6B |
| Employees | 1,490 |
The risks · The things to watch: its business and earnings are exposed to Saudi Arabia and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade1030.SR trades on TADAWUL (the company is based in Saudi Arabia). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (6 analysts) rates it buy, with a mean price target of $15.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (6 analysts) rates it buy, with a mean price target of $15.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (6 analysts) rates it buy, with a mean price target of $15.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (6 analysts) rates it buy, with a mean price target of $15.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $13.05 | +1.1% | $0.30 | $1,034 | +3.4% |
| 2 months | $13.14 | +0.5% | $0.30 | $1,027 | +2.7% |
| 3 months | $12.46 | +6.0% | $0.30 | $1,084 | +8.4% |
| 6 months | $12.97 | +1.7% | $0.30 | $1,041 | +4.1% |
| 1 year | $13.72 | -3.8% | $0.70 | $1,013 | +1.3% |
| 2 years | $11.98 | +10.2% | $1.46 | $1,224 | +22.4% |
| 3 years | $11.77 | +12.1% | $2.14 | $1,303 | +30.3% |
| 5 years | $8.29 | +59.3% | $3.16 | $1,974 | +97.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever 1030.SR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.